125 related articles for article (PubMed ID: 15675577)
1. [Second-line chemotherapy for advanced colorectal cancer].
Uetake H; Iida S; Tsunozaki H; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Gan To Kagaku Ryoho; 2005 Jan; 32(1):24-7. PubMed ID: 15675577
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress of chemotherapy for colorectal cancer].
Ishiguro A; Shitara K; Munakata M; Saitoh S; Sakata Y
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2017-23. PubMed ID: 16352922
[TBL] [Abstract][Full Text] [Related]
3. [Progress in chemotherapy for colorectal cancer].
Sasaki T; Maeda Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy for colorectal carcinoma].
Uetake H; Higuchi T; Enomoto M; Sugihara K
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1889-94. PubMed ID: 14650955
[TBL] [Abstract][Full Text] [Related]
5. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.
Sheikh HY; Valle JW; Palmer K; Sjursen A; Craven O; Wilson G; Swindell R; Saunders MP
Br J Cancer; 2007 Jan; 96(1):38-43. PubMed ID: 17213824
[TBL] [Abstract][Full Text] [Related]
6. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Ito T; Hata Y; Matsuoka S; Nakajima N; Yokoyama R; Honda S; Sano F; Akasaka Y; Ohmori K
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1289-93. PubMed ID: 16184926
[TBL] [Abstract][Full Text] [Related]
8. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
[TBL] [Abstract][Full Text] [Related]
9. A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304.
Ishida H; Miyake Y; Fukunaga M; Watanabe Y; Kato T; Takemoto H; Furukawa H
Jpn J Clin Oncol; 2009 Sep; 39(9):601-5. PubMed ID: 19535386
[TBL] [Abstract][Full Text] [Related]
10. Treatment of colorectal cancer metastasis: the role of chemotherapy.
Xiong HQ; Ajani JA
Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155
[TBL] [Abstract][Full Text] [Related]
11. [Controversy of treatment for advanced colorectal cancer--intermedisine].
Sato A; Shimada K; Taguchi S
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404
[TBL] [Abstract][Full Text] [Related]
12. [IFL].
Yamazaki K; Yoshino T; Boku N
Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Carmichael J; Popiela T; Radstone D; Falk S; Borner M; Oza A; Skovsgaard T; Munier S; Martin C
J Clin Oncol; 2002 Sep; 20(17):3617-27. PubMed ID: 12202662
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
15. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
Goto A
Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for colorectal cancer.
Goyle S; Maraveyas A
Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer: chemotherapy treatment overview.
Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of quality of life by questionnaires between S-1/CPT-11 and mFOLFOX6 in patients with advanced colorectal cancer].
Tokunaga Y; Sasaki H; Matsueda S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1127-31. PubMed ID: 21772096
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy].
Aiba K
Gan To Kagaku Ryoho; 2004 May; 31(5):706-11. PubMed ID: 15170977
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]